Severe malaria in Gabon: epidemiological, clinical and laboratory features in Amissa Bongo Hospital of Franceville.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
09 Mar 2023
Historique:
received: 20 10 2022
accepted: 23 02 2023
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

Malaria is the most deadly parasitic disease and continues to claim more than a half million of deaths across the world each year, mainly those of under-fives children in sub-Saharan Africa. The aim of this study was to determine the epidemiological, clinical and laboratory features of patients with severe malaria at the Centre Hospitalier Régional Amissa Bongo (CHRAB), a referral hospital in Franceville. It was an observational descriptive study conducted at CHRAB over 10 months. All admitted patients at the emergency ward of all ages presenting with positive test to falciparum malaria diagnosed by microscopy and rapid test with clinical signs of severe illness describe by World Health Organization were enrolled. During this study, 1065 patients were tested positive for malaria, of them 220 had severe malaria. Three quarters (75.0%) were less than 5 years of age. The mean time to consultation was 3.5 ± 1 days. The most frequent signs of severity on admission were dominated by neurological disorders 92.27% (prostration 58.6% and convulsion 24.1%), followed by severe anemia 72.7%, hyperlactatemia 54.6%, jaundice 25% and respiratory distress 21.82%.The other forms such as hypoglycemia, haemoglobinuria, renal failure were found in low proportions < 10%. Twenty-one patients died, coma (aOR = 15.54, CI 5.43-44.41, p < 0.01), hypoglycemia (aOR = 15.37, CI 2.17-65.3, p < 0.01), respiratory distress (aOR = 3.85, CI 1.53-9.73, p = 0.004) and abnormal bleeding (aOR = 16.42, CI 3.57-104.73, p = 0.003) were identified as independent predictors of a fatal outcome. Anemia was associated with decreased mortality. Severe malaria remains a public health problem affecting mostly children under 5 years. Classification of malaria helps identify the most severely ill patients and aids early and appropriate management of the severe malaria cases.

Sections du résumé

BACKGROUND BACKGROUND
Malaria is the most deadly parasitic disease and continues to claim more than a half million of deaths across the world each year, mainly those of under-fives children in sub-Saharan Africa. The aim of this study was to determine the epidemiological, clinical and laboratory features of patients with severe malaria at the Centre Hospitalier Régional Amissa Bongo (CHRAB), a referral hospital in Franceville.
METHODS METHODS
It was an observational descriptive study conducted at CHRAB over 10 months. All admitted patients at the emergency ward of all ages presenting with positive test to falciparum malaria diagnosed by microscopy and rapid test with clinical signs of severe illness describe by World Health Organization were enrolled.
RESULTS RESULTS
During this study, 1065 patients were tested positive for malaria, of them 220 had severe malaria. Three quarters (75.0%) were less than 5 years of age. The mean time to consultation was 3.5 ± 1 days. The most frequent signs of severity on admission were dominated by neurological disorders 92.27% (prostration 58.6% and convulsion 24.1%), followed by severe anemia 72.7%, hyperlactatemia 54.6%, jaundice 25% and respiratory distress 21.82%.The other forms such as hypoglycemia, haemoglobinuria, renal failure were found in low proportions < 10%. Twenty-one patients died, coma (aOR = 15.54, CI 5.43-44.41, p < 0.01), hypoglycemia (aOR = 15.37, CI 2.17-65.3, p < 0.01), respiratory distress (aOR = 3.85, CI 1.53-9.73, p = 0.004) and abnormal bleeding (aOR = 16.42, CI 3.57-104.73, p = 0.003) were identified as independent predictors of a fatal outcome. Anemia was associated with decreased mortality.
CONCLUSION CONCLUSIONS
Severe malaria remains a public health problem affecting mostly children under 5 years. Classification of malaria helps identify the most severely ill patients and aids early and appropriate management of the severe malaria cases.

Identifiants

pubmed: 36894964
doi: 10.1186/s12936-023-04512-7
pii: 10.1186/s12936-023-04512-7
pmc: PMC9996888
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Informations de copyright

© 2023. The Author(s).

Références

Acta Trop. 2003 Mar;85(3):355-61
pubmed: 12659973
Niger J Clin Pract. 2018 Oct;21(10):1349-1355
pubmed: 30297570
Med Mal Infect. 2004 Feb;34(2):86-91
pubmed: 15620020
Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):510-4
pubmed: 23394850
BMC Med. 2017 Aug 3;15(1):147
pubmed: 28768513
J Infect Public Health. 2020 Oct;13(10):1469-1472
pubmed: 32360023
BMC Infect Dis. 2012 Sep 13;12:216
pubmed: 22973831
Am J Trop Med Hyg. 2017 Nov;97(5):1513-1523
pubmed: 29016322
Malar Res Treat. 2016;2016:1240962
pubmed: 27047701
Malar J. 2016 Aug 18;15(1):420
pubmed: 27538948
Sante. 2011 Oct-Dec;21(4):193-8
pubmed: 22362010
Trans R Soc Trop Med Hyg. 2005 Apr;99(4):243-51
pubmed: 15708383
Am J Trop Med Hyg. 2001 Nov;65(5):599-602
pubmed: 11716121
Sante. 1997 Jan-Feb;7(1):13-7
pubmed: 9172871
Bull Soc Pathol Exot. 2004 Nov;97(4):239-43
pubmed: 17304741
PLoS Med. 2020 Oct 19;17(10):e1003359
pubmed: 33075101
Br J Biomed Sci. 2002;59(4):228-31
pubmed: 12572958
J Infect Dis. 2009 Jan 1;199(1):142-50
pubmed: 19086817
Bull Soc Pathol Exot. 2003 Aug;96(3):156-60
pubmed: 14582287
Rev Inst Med Trop Sao Paulo. 1993 Jan-Feb;35(1):93-102
pubmed: 8278749
Malar J. 2005 Jan 09;4:1
pubmed: 15638948
Bull Soc Pathol Exot. 1999 Jul;92(3):153-6
pubmed: 10472438
Diagn Microbiol Infect Dis. 2010 Feb;66(2):162-8
pubmed: 19846265
Arch Dis Child. 1995 Apr;72(4):334-6
pubmed: 7763067
Med Mal Infect. 2011 Feb;41(2):63-7
pubmed: 21495278
Parasite. 2016;23:32
pubmed: 27492564
PLoS One. 2013;8(3):e58686
pubmed: 23505549
Am J Trop Med Hyg. 2004 Aug;71(2):167-72
pubmed: 15306705

Auteurs

Roméo Karl Imboumy-Limoukou (RK)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon. imboumykarl@gmail.com.

Judicael Boris Lendongo-Wombo (JB)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.
Ecole Doctorale Régionale d'Afrique Centrale en Infectiologie Tropicale (ECODRAC), Université Des Sciences Et Techniques de Masuku, BP 876, Franceville, Gabon.
Département d'épidémiologie, Biostatistiques Et Informatique Médicale, Université Des Sciences de La Santé (USS), BP 18231, Libreville, Gabon.

Andhra Fecilia Nguimbyangue-Apangome (AF)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.

Jean-Claude Biteghe Bi Essone (JC)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.

Franck Mounioko (F)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.
Département de Biologie, Université Des Sciences Et Techniques de Masuku (USTM), BP 901, Franceville, Gabon.

Lydie Sandrine Oyegue-Libagui (LS)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.
Ecole Doctorale Régionale d'Afrique Centrale en Infectiologie Tropicale (ECODRAC), Université Des Sciences Et Techniques de Masuku, BP 876, Franceville, Gabon.
Département de Biologie, Université Des Sciences Et Techniques de Masuku (USTM), BP 901, Franceville, Gabon.

Brice Edgar Ngoungou (BE)

Département d'épidémiologie, Biostatistiques Et Informatique Médicale, Université Des Sciences de La Santé (USS), BP 18231, Libreville, Gabon.

Jean-Bernard Lekana-Douki (JB)

Unité Ecologie Evolution et Résistances Parasitaires (UNEEREP), Centre International de Recherches Médicales de Francevillev, BP 769, Franceville, Gabon.
Département de Parasitologie-Mycologie, Université Des Sciences de La Santé, BP 18231, Libreville, Gabon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH